EON

Boston (EON) – The FDA has put out a new warning in regards to an anti-clotting drug by the name of Trasylol.

The FDA stated that the drug is used to prevent excessive bleeding during heart bypass surgery, but may also increase the risk of death as well.

The new warning by the FDA comes after a Canadian trial looked into the drug further as they found that there was an increase in the number of patients using it. The Bayer AG drug showed results that stated that it increased the risk of death when compared directly to other drugs.

Trasylol was first approved by the FDA in 1993 to limit the blood loss in patients during cardiac surgery.

Bayer stated,f ollowing the new FDA warning, that “physicians use Trasylol only in accordance with approved product labeling.”

The manufacturer stated that the drug “remains a safe and effective treatment option for physicians.”